AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 17, 2024
Similar genetic changes in two different types of brain cells may contribute to cognitive impairment in schizophrenia and aging. US researchers examined gene expression in more than a million brain cells collected post-mortem from 191 donors.
Bio Pharma Dive
MARCH 17, 2024
The biotech, formed as a successor to a company Roche acquired in 2018, has two drugs in clinical testing for neurological and immune diseases.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 17, 2024
The Department of Pharmaceuticals (DoP) has issued a new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, permitting pharma companies to provide brand reminders such as informational and education items and free samples to medical professionals with restrictions on sample packs and total value.
Pharma Mirror
MARCH 17, 2024
Finding the right dentist in Whittier can be daunting, but it’s crucial for maintaining oral health. From routine check-ups to specialized treatments, a reliable dentist can make all the difference. In this article, we’ll walk you through five essential steps to help you find the best dentist in Whittier for your specific needs. So, let’s dive right in!
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioSpace
MARCH 17, 2024
With Boehringer Ingelheim’s announcement earlier this month that it was capping U.S. inhaler costs at $35 per month, AstraZeneca on Monday followed suit.
Cloudbyz
MARCH 17, 2024
In the dynamic world of life sciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its Life Sciences Cloud marks a significant stride towards this goal. Combined with Cloudbyz eClinical which is built natively on the Salesforce platform, this collaboration promises to revolutionize the way life science organizations manage their clinic
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Drug Patent Watch
MARCH 17, 2024
Five years of exclusivity is provided for drugs which do not contain active molecules that have appeared in previously-approved drugs.
BioSpace
MARCH 17, 2024
The FDA will close out a hectic month of March with a flurry of target action dates, including ones for lymphoma and CKD anemia treatments.
Drug Patent Watch
MARCH 17, 2024
Rifaximin is the generic ingredient in one branded drug marketed by Salix Pharms and is included in one NDA. There are twenty-nine patents protecting this compound.
BioSpace
MARCH 17, 2024
Following GSK’s lead, Pfizer plans to lower its interest in Haleon from 32% to approximately 24%, with the sale of 630 million ordinary shares in the consumer healthcare spinoff.
Drug Patent Watch
MARCH 17, 2024
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.
BioSpace
MARCH 17, 2024
AstraZeneca reported Monday that adding Lynparza to Imfinzi improved outcomes in mismatch repair proficient endometrial cancer, more than doubling the median duration of response in patients.
JAMA Internal Medicine
MARCH 17, 2024
This Viewpoint examines why investigators should address women’s health in all biomedical and health-related research.
BioSpace
MARCH 17, 2024
New late-stage trial results for GSK’s Jemperli show improved overall and progression-free survival in a broader range of endometrial cancer patients, which could lead to a potential label expansion.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioSpace
MARCH 17, 2024
Contineum Therapeutics joined the biotech 2024 initial public offering class on Friday with an SEC filing. The biotech will use the IPO proceeds to complete a Phase II trial for its most mature candidate targeting multiple sclerosis.
BioSpace
MARCH 17, 2024
Knowing that you want to integrate AI is one thing—but how do you actually do it? For biotech companies kickstarting their generative AI journey, here are four things to consider.
Expert insights. Personalized for you.
231 
Let's personalize your content